DEBRISOQUINE 4-HYDROXYLASE (CYP2D) LOCUS AND POSSIBLE SUSCEPTIBILITY TO SCHIZOPHRENIA

被引：20
|
作者：
VALLADA, H
COLLIER, D
DAWSON, E
OWEN, M
NANKO, S
MURRAY, R
GILL, M
机构：
[1] TEIKYO UNIV,SCH MED,DEPT PSYCHIAT,TOKYO 173,JAPAN
[2] UNIV WALES COLL MED,DEPT PSYCHOL MED,CARDIFF CF4 4XN,S GLAM,WALES
来源：
LANCET | 1992年 / 340卷 / 8812期
关键词：
D O I：
10.1016/0140-6736(92)93266-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：181 / 182
页数：2
相关论文
共 50 条
  • [21] INHERITED AMPLIFICATION OF AN ACTIVE GENE IN THE CYTOCHROME-P450 CYP2D LOCUS AS A CAUSE OF ULTRARAPID METABOLISM OF DEBRISOQUINE
    JOHANSSON, I
    LUNDQVIST, E
    BERTILSSON, L
    DAHL, ML
    SJOQVIST, F
    INGELMANSUNDBERG, M
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (24) : 11825 - 11829
  • [22] Debrisoquine hydroxylase (CYP2D6) and prostate cancer
    Febbo, PG
    Kantoff, PW
    Giovannucci, E
    Brown, M
    Chang, G
    Hennekens, CH
    Stampfer, M
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1998, 7 (12) : 1075 - 1078
  • [23] TIME COURSE OF INHIBITION BY QUINIDINE OF DEBRISOQUINE 4-HYDROXYLASE ACTIVITY IN MAN
    KOBAYASHI, S
    SPEIRS, CJ
    WATSON, D
    MURRAY, S
    SESARDIC, D
    BOOBIS, AR
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 25 (05) : P673 - P674
  • [24] GENETIC EXPRESSION OF THE DEBRISOQUINE 4-HYDROXYLASE POLYMORPHISM IN HUMAN-LYMPHOCYTES
    REDLICH, CA
    JUILFS, DM
    OMIECINSKI, CJ
    CLINICAL RESEARCH, 1989, 37 (02): : A341 - A341
  • [25] A RADIOMETRIC ASSAY FOR DEBRISOQUINE 4-HYDROXYLASE IN HUMAN-LIVER MICROSOMES
    NAKANO, M
    INABA, T
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1984, 62 (01) : 84 - 88
  • [26] SEX AND STRAIN DIFFERENCES IN HEPATIC DEBRISOQUINE 4-HYDROXYLASE ACTIVITY OF THE RAT
    KAHN, GC
    RUBENFIELD, M
    DAVIES, DS
    MURRAY, S
    BOOBIS, AR
    DRUG METABOLISM AND DISPOSITION, 1985, 13 (04) : 510 - 516
  • [27] Selective deficiency of debrisoquine 4-hydroxylase activity in mouse liver microsomes
    Masubuchi, Y
    Iwasa, T
    Hosokawa, S
    Suzuki, T
    Horie, T
    Imaoka, S
    Funae, Y
    Narimatsu, S
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1997, 282 (03): : 1435 - 1441
  • [28] No allelic association between harm avoidance and the debrisoquine 4-hydroxylase gene
    Veefkind, AH
    Ingenhoven, TJM
    de Groot, IW
    ACTA NEUROPSYCHIATRICA, 2002, 14 (05) : 216 - 218
  • [29] THE DEMETHYLENATION OF METHYLENEDIOXYMETHAMPHETAMINE (ECSTASY) BY DEBRISOQUINE HYDROXYLASE (CYP2D6)
    TUCKER, GT
    LENNARD, MS
    ELLIS, SW
    WOODS, HF
    CHO, AK
    LIN, LY
    HIRATSUKA, A
    SCHMITZ, DA
    CHU, TYY
    BIOCHEMICAL PHARMACOLOGY, 1994, 47 (07) : 1151 - 1156
  • [30] Debrisoquine hydroxylase gene polymorphism (CYP2D6*4) in dementia with Lewy bodies
    Huckvale, C
    Richardson, AMT
    Mann, DMA
    Pickering-Brown, SM
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (01): : 135 - 136
12345